Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for October 29th

Read MoreHide Full Article

Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 29th:

Pampa Energia S.A. : This integrated electricity company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 32.8% over the last 90 days.

Pampa Energia has a price-to-earnings ratio (P/E) of 3.5, compared with 17.6 for the industry. The company possesses a Value Score of A.

Sappi Limited (SPPJY - Free Report) : This woodfibre company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its next year earnings rising 4.6% over the last 60 days.

Sappi Ltd. Price and Consensus

Sappi Ltd. Price and Consensus

Sappi Ltd. price-consensus-chart | Sappi Ltd. Quote

Sappi has a price-to-earnings ratio (P/E) of 4.04, compared with 10.3 for the industry. The company possesses a Value Score of A.

Sappi Ltd. PE Ratio (TTM)

Sappi Ltd. PE Ratio (TTM)

Sappi Ltd. pe-ratio-ttm | Sappi Ltd. Quote

Jounce Therapeutics, Inc. (JNCE - Free Report) : This clinical-stage immunotherapy company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 90 days.

Jounce Therapeutics has a price-to-earnings ratio (P/E) of 2.32, compared with 9 for the industry. The company possesses a Value Score of B.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Sappi Ltd. (SPPJY) - free report >>

Jounce Therapeutics, Inc. (JNCE) - free report >>